Primary hyperparathyroidism: Difference between revisions
Jump to navigation
Jump to search
| Line 41: | Line 41: | ||
==Treatment== | ==Treatment== | ||
[[Primary hyperparathyroidism medical therapy|Medical Therapy]] | [[Primary hyperparathyroidism surgery|Surgery]] | [[Primary hyperparathyroidism | [[Primary hyperparathyroidism medical therapy|Medical Therapy]] | [[Primary hyperparathyroidism surgery|Surgery]] | [[Primary hyperparathyroidism prevention|Prevention]] | [[Primary hyperparathyroidism cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Primary hyperparathyroidism future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
:[[Primary hyperparathyroidism case study one|Case #1]] | :[[Primary hyperparathyroidism case study one|Case #1]] | ||
Revision as of 17:47, 20 September 2012
For patient information click here
| Primary hyperparathyroidism | |
 | |
|---|---|
| Thyroid and parathyroid. | |
| ICD-10 | E21.0 |
| ICD-9 | 252.01 |
| DiseasesDB | 6283 |
| MeSH | D049950 |
Template:Primary hyperparathyroidism Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Primary Hyperparathyroidism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters